| Q27006805 | A critical review of diabetes, glycemic control, and dental implant therapy |
| Q91982037 | AdipoRon promotes diabetic fracture repair through endochondral ossification-based bone repair by enhancing survival and differentiation of chondrocytes |
| Q35878806 | Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways. |
| Q46589241 | Alloxan-induced diabetes delays repair in a rat model of closed tibial fracture |
| Q50725306 | Altered expression of SDF-1 and CXCR4 during fracture healing in diabetes mellitus. |
| Q47881918 | Bioinformatics analysis of gene expression profile in callus tissues of osteoporotic phenotype mice induced by osteoblast-specific Krm2 overexpression |
| Q36117590 | Characteristics of inflammation common to both diabetes and periodontitis: are predictive diagnosis and targeted preventive measures possible? |
| Q27691805 | Dental implant survival in diabetic patients; review and recommendations |
| Q37238865 | Diabetes causes the accelerated loss of cartilage during fracture repair which is reversed by insulin treatment. |
| Q36553573 | Diabetes mellitus and periodontal diseases |
| Q37600798 | Diabetes mellitus impairs tendon-bone healing after rotator cuff repair |
| Q37101627 | Diabetes-related impairment in bone strength is established early in the life course |
| Q35029163 | Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity |
| Q51669032 | Effect of Choline on the Composition and Degradation Enzyme of Extracellular Matrix of Mice Chondrocytes Exposed to Fluoride. |
| Q46035962 | Effects of local insulin delivery on subperiosteal angiogenesis and mineralized tissue formation during fracture healing. |
| Q33996284 | Glycemic control and implant stabilization in type 2 diabetes mellitus |
| Q37362094 | High levels of tumor necrosis factor-alpha contribute to accelerated loss of cartilage in diabetic fracture healing |
| Q46508853 | Imbalance of RANK, RANKL and OPG expression during tibial fracture repair in diabetic rats |
| Q90419968 | Impact of Diabetes Mellitus on Bone Health |
| Q38162668 | Impact of diabetes mellitus on surgical outcomes in sports medicine. |
| Q91329973 | In vivo Labeling of Bone Microdamage in an Animal Model of Type 1 Diabetes Mellitus |
| Q36281802 | Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues |
| Q61443943 | Leptin-deficient mice have altered three-dimensional growth plate histomorphometry |
| Q41157812 | Nonunion Risk Assessment in Foot and Ankle Surgery: Proposing a Predictive Risk Assessment Model |
| Q53868415 | Oral Manifestations of Diabetes. |
| Q42028937 | Osteogenic protein-1 overcomes inhibition of fracture healing in the diabetic rat: a pilot study |
| Q38951563 | Perceived risk factors for nonunion following foot and ankle arthrodesis |
| Q28078743 | Sweet Bones: The Pathogenesis of Bone Alteration in Diabetes |
| Q94554864 | Systemic Parathyroid Hormone Enhances Fracture Healing in Multiple Murine Models of Type 2 Diabetes Mellitus |
| Q40982198 | The effect of locally delivered recombinant human bone morphogenetic protein-2 with hydroxyapatite/tri-calcium phosphate on the biomechanical properties of bone in diabetes-related osteoporosis. |
| Q35491946 | The effects of elevated hemoglobin A(1c) in patients with type 2 diabetes mellitus on dental implants: Survival and stability at one year |
| Q57665436 | What is the role of systemic conditions and options for manipulation of bone formation and bone resorption in rotator cuff tendon healing and repair? |